Aurotioprol API Manufacturers & Suppliers
0 verified results
Commercial-scale Suppliers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Total market transparency
Supplier trade data access
Buyer / supplier flow comparison
Aurotioprol | CAS No: 27279-43-2 | GMP-certified suppliers
A medication that serves as a specific antirheumatic agent with potential antiinflammatory benefits for musculoskeletal disorders involving inflammation.
Therapeutic categories
Product Snapshot
- Aurotioprol is an oral small molecule formulation
- It is primarily investigated for anti-inflammatory applications
- The compound is currently in the experimental stage with no formal regulatory approvals
Clinical Overview
Due to its experimental status, comprehensive pharmacodynamics and mechanism of action profiles for Aurotioprol are not available. Generally, gold-based compounds exert effects thought to modulate immune responses and inflammatory pathways, which may involve inhibition of inflammatory mediators and modulation of cellular components implicated in rheumatic diseases.
Pharmacokinetic parameters, including absorption, distribution, metabolism, and excretion (ADME) of Aurotioprol, have not been characterized in publicly available data. Comparable gold-containing agents typically exhibit complex biodistribution with tissue accumulation, and prolonged half-life, often requiring careful dosing and monitoring.
Safety and toxicity data specific to Aurotioprol remain undefined. Historically, gold compounds used in antiinflammatory therapy have been associated with adverse effects such as dermatologic reactions, renal toxicity, and hematologic abnormalities. Therefore, rigorous toxicological evaluation is necessary before clinical application.
No notable marketed brands or approved formulations of Aurotioprol are currently documented. Its experimental classification indicates the compound is not commercially available for routine therapeutic use.
For sourcing and quality control of Aurotioprol as an API, it is essential to ensure compliance with stringent purity specifications and to verify the absence of contaminants relevant to organometallic compounds. Stability profiling, batch-to-batch consistency, and robust analytical characterization are critical due to the potential toxicological risks associated with gold and sulfur-containing therapeutic agents.
Identification & chemistry
| Generic name | Aurotioprol |
|---|---|
| Molecule type | Small molecule |
| CAS | 27279-43-2 |
| UNII | G7097J63E9 |
| DrugBank ID | DB13763 |
Formulation & handling
- Aurotioprol is a small molecule with high water solubility, suitable for oral formulations. Its low LogP indicates low lipophilicity, potentially influencing absorption and formulation design. Stability and handling data are limited due to its experimental status; rigorous evaluation is recommended.
Regulatory status
Aurotioprol is a type of Antidotes, Deterrents, and Toxicologic Agents
Antidotes, Deterrents, and Toxicologic Agents are an important category of pharmaceutical Active Pharmaceutical Ingredients (APIs) that play a critical role in healthcare and toxicology. These substances are designed to counteract the effects of poisons, toxins, and overdoses, thereby saving lives and preventing severe health consequences.
Antidotes are substances that neutralize the toxic effects of certain drugs, chemicals, or poisons. They work by either directly binding to the toxic substance or by blocking its harmful actions on the body. Antidotes are administered in emergency situations to quickly reverse the effects of poisoning and restore normal physiological functions.
Deterrents, on the other hand, are pharmaceutical agents used to discourage or prevent harmful behaviors, such as substance abuse. They are designed to make the ingestion or misuse of certain substances unpleasant or less desirable. Deterrents can be formulated to cause unpleasant side effects, such as nausea or vomiting, when a particular substance is consumed in excessive amounts.
Toxicologic agents encompass a broad range of pharmaceutical APIs used in toxicology studies and research. These substances are employed to investigate the toxicity, metabolism, and mechanisms of action of various chemicals and compounds. Toxicologic agents are vital for understanding the potential hazards and risks associated with certain substances, ensuring the safety of drugs, and developing effective treatments for poisoning cases.
In conclusion, Antidotes, Deterrents, and Toxicologic Agents are essential categories of pharmaceutical APIs that address poisoning emergencies, deter harmful behaviors, and enable toxicological research. Their development and availability are crucial for safeguarding public health, enhancing patient care, and advancing our understanding of toxicology.
